What is MaxCyte's total equity?

MaxCyte (MXCT) reported total equity of $167.89M in Q1 2026.

How has MaxCyte's total equity changed year-over-year?

MaxCyte's total equity decreased by 15.8% year-over-year, from $199.41M to $167.89M.

What is the long-term trend for MaxCyte's total equity?

Over 5 years (2020 to 2025), MaxCyte's total equity has grown at a 38.9% compound annual growth rate (CAGR), from $33.23M to $171.49M.

What does total equity mean?

Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.

MaxCyte MXCT Total Equity

Total Equity at other companies

Bio-Rad LaboratoriesBIO

$6.85B+2.6%

Thermo Fisher ScientificTMO

$51.93B+5.2%

Ginkgo BioworksDNA

$443.15M-31.6%

Immix Biopharma, Inc.IMMX

$84.36M+779%

Rapid Micro BiosystemsRPID

$20.4M-68.9%

PDE

Pro-Dex, Inc.PDEX

$45.2M+28.1%

Other financials

Income statement

See full

Revenue$9.7M-7.1%

Gross profit$8.1M-9.1%

Operating income-$6.2M+49.7%

Net income-$4.8M+53.7%

EPS (diluted)-$0.04+60.0%

Balance sheet

See full

Cash & equivalents$14.6M-37.8%

Total debt$17.5M-7.1%

Total assets$194.5M-15.4%

Cash flow

See full

Operating cash flow-$8.2M+43.3%

CapEx$72.0K-89.0%

Free cash flow-$8.2M+45.3%

Valuation

See full

Market cap$130.15M-46.8%

Enterprise value$133.08M-46.3%

P/S4×-2.8×

Profitability

See full

Gross margin80.5%-0.4pp

Operating margin-141.8%+6.4pp

Net margin-121.2%+12.3pp

FCF margin-90.9%+3.7pp

Returns & leverage

See full

Return on equity-21.3%+2.0pp

Debt / equity0.1×0.0×

Current ratio12×-0.2×

Where this comes from

Reported directly by MaxCyte in its filing.

Tagged under the XBRL concept us-gaap:StockholdersEquity.

The official record: MaxCyte’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about MaxCyte's total equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is MaxCyte's total equity?: MaxCyte (MXCT) reported total equity of $167.89M in Q1 2026.
How has MaxCyte's total equity changed year-over-year?: MaxCyte's total equity decreased by 15.8% year-over-year, from $199.41M to $167.89M.
What is the long-term trend for MaxCyte's total equity?: Over 5 years (2020 to 2025), MaxCyte's total equity has grown at a 38.9% compound annual growth rate (CAGR), from $33.23M to $171.49M.
What does total equity mean?: Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.